New research presented at the AACR Annual Meeting 2026 offers hope for people with high-risk smoldering multiple myeloma (SMM), which is a condition that can develop into active multiple myeloma. In a small phase II clinical trial called CAR-PRISM, researchers found that a single infusion of the CAR T-cell therapy ciltacabtagene autoleucel (Carvykti) led to […]

We had the privilege of hosting Dr. Saad Z. Usmani, Chief of Myeloma Service at Memorial Sloan Kettering Cancer Center, for a recent webinar. In the discussion, he breaks down how multiple myeloma treatment works and why care can look different from person to person. Watch the full webinar What is multiple myeloma? Multiple myeloma […]

In this Q&A, Dr. Saad Usmani, Chief of Myeloma Service at Memorial Sloan Kettering Cancer Center, answers questions from patients about what their diagnosis means today, how treatment decisions are made, and how new breakthroughs are changing what is possible in 2026 and beyond. Learn more about CAR-T therapies, bispecific antibodies, and precision-based drug combinations […]

When you’re living with multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), or smoldering multiple myeloma (SMM), your lifestyle choices can play a meaningful role in your overall health. Emerging research suggests that dietary fiber may slow disease progression and aid in recovery. While fiber has long been associated with heart and gut health, recent […]

When you’re diagnosed with multiple myeloma, you’ll likely hear your care team talk about genes, mutations, and chromosomal changes. This can be a complex topic, but having an overview of what these terms mean can help you better understand your treatment options and have deeper discussions with your care team. Keep reading for a simple […]

Multiple myeloma, a type of blood cancer, remains a challenging cancer to treat, but new advances are helping patients manage the disease more effectively. While it’s not considered curable, recent advances are not only extending lives but also improving the quality of life for many patients. Here’s an overview of the new research that’s transforming […]

Multiple myeloma is a type of blood cancer that begins in plasma cells, a kind of white blood cell found in the bone marrow. Unlike solid tumors, myeloma doesn’t form a single mass, so staging looks different compared to cancers that are solid. Instead, a specific staging system is used to look at lab results, […]

Multiple myeloma is a type of blood cancer that begins in plasma cells, a kind of white blood cell found in the bone marrow. About 36,000 new cases are diagnosed each year, making up roughly 2% of all cancers. Multiple myeloma can affect bones, kidneys, and the immune system, so the disease and its treatments […]